Company intelligence / Profile preview

Multicare Pharma

Ownership: Private
Development stage: Commercial

Overview

Multicare Pharma refers to several active pharmaceutical companies operating under similar names across different countries. The Brazilian entity specializes in licensing and distributing high-tech medicines for rare and complex diseases through partnerships with multinational firms. The Egyptian company manufactures and markets over 69 products including pharmaceuticals and medical devices. In the Philippines, it ranks among the top branded generic providers with a broad portfolio covering major therapeutic areas as part of Lupin Limited's group.

Therapeutic areas: PulmonologyOncologyEndocrinologyRare DiseasesOtherRheumatologyGastroenterologyNeurologyWomen's Health
Modalities: Small moleculesBranded genericsHigh-tech innovative medicinesSupplementsCosmeticsMedical devices
Industry: Biotech

Partnerships

Leading multinational pharmaceutical firms (for licensing/importing products into Latin America/Brazil)

Beyond the preview

Go deeper on Multicare Pharma.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Multicare Pharma.

Explore the full profile